Click on a filter below to refine your search. Remove a filter to broaden your search.
Under the law, Medicare will now be allowed to negotiate the cost of some drugs, and vaccines will be free for Part D recipients.
The drug shows promise in clearing the brain plaques believed to play a role in Alzheimer’s disease.
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.